12-52951512-G-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000224.3(KRT18):c.689G>C(p.Ser230Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00569 in 1,614,086 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000224.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KRT18 | NM_000224.3 | c.689G>C | p.Ser230Thr | missense_variant | 4/7 | ENST00000388835.4 | |
KRT18 | NM_199187.2 | c.689G>C | p.Ser230Thr | missense_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KRT18 | ENST00000388835.4 | c.689G>C | p.Ser230Thr | missense_variant | 4/7 | 1 | NM_000224.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00399 AC: 607AN: 152222Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00360 AC: 904AN: 251354Hom.: 5 AF XY: 0.00381 AC XY: 518AN XY: 135892
GnomAD4 exome AF: 0.00587 AC: 8575AN: 1461746Hom.: 41 Cov.: 33 AF XY: 0.00573 AC XY: 4169AN XY: 727184
GnomAD4 genome ? AF: 0.00398 AC: 606AN: 152340Hom.: 3 Cov.: 32 AF XY: 0.00369 AC XY: 275AN XY: 74502
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2Other:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The KRT18 p.Ser230Thr variant was not identified in the literature nor was it identified in Cosmic, however it was identified in dbSNP (ID: rs58472472), ClinVar (clinical significance not provided) and LOVD 3.0. The variant was identified in control databases in 1028 of 282750 chromosomes (6 homozygous) at a frequency of 0.003636 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 785 of 129112 chromosomes (freq: 0.00608), Other in 25 of 7214 chromosomes (freq: 0.003465), Latino in 91 of 35440 chromosomes (freq: 0.002568), South Asian in 58 of 30616 chromosomes (freq: 0.001894), African in 33 of 24930 chromosomes (freq: 0.001324), European (Finnish) in 26 of 25120 chromosomes (freq: 0.001035) and Ashkenazi Jewish in 10 of 10370 chromosomes (freq: 0.000964); it was not observed in the East Asian population. This variant was identified in 2/329 German patients with chronic hepatitis C, 2/344 patients with acute liver failure and 4/97 patients with IBD (Strnad_2006_PMID: 16729313; Strnad_2010_PMID: 20538000; Owens_2004_PMID: 15090596). However it should be noted that the authors from these studies referred to this variant as a polymorphism rather than a mutation and did not suspect significant biological relevance. Further, functional in vitro studies of this variant in cell models suggested conflicting results regarding the potential pathogenicity of this variant (Owens_2004_PMID: 15090596; Zupancic_2014_PMID: 24915158). The p.Ser230 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 31, 2019 | - - |
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2022 | KRT18: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at